These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Severe hypotension due to the use of bretylium for postcardiotomy ventricular arrhythmias. Kron IL; Nolan SP Ann Thorac Surg; 1983 Mar; 35(3):271-3. PubMed ID: 6600915 [TBL] [Abstract][Full Text] [Related]
4. Oral bretylium tosylate use during pregnancy and subsequent breastfeeding: a case report. Gutgesell M; Overholt E; Boyle R Am J Perinatol; 1990 Apr; 7(2):144-5. PubMed ID: 2331276 [TBL] [Abstract][Full Text] [Related]
7. Paradoxical ventricular tachycardia and fibrillation after intravenous bretylium therapy. Report of two cases. Anderson JL; Popat KD; Pitt B Arch Intern Med; 1981 May; 141(6):801-2. PubMed ID: 7235792 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic reversal of hypotensive effect complicating antiarrhythmic therapy with bretylium. Woosley RL; Reele SB; Roden DM; Nies AS; Oates JA Clin Pharmacol Ther; 1982 Sep; 32(3):313-21. PubMed ID: 7105622 [No Abstract] [Full Text] [Related]
9. Bretylium and dobutamine in the treatment of coronary artery disease. Frishman WH Bull N Y Acad Med; 1979 Sep; 55(8):798-809. PubMed ID: 290401 [No Abstract] [Full Text] [Related]
11. Efficacy of bretylium tosylate for ventricular tachycardia. Chandrasekaran S; Steinberg JS Am J Cardiol; 1999 Jan; 83(1):115-7, A9. PubMed ID: 10073797 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of bretylium in man after intravenous administration. Narang PK; Adir J; Josselson J; Yacobi A; Sadler J J Pharmacokinet Biopharm; 1980 Aug; 8(4):363-72. PubMed ID: 7431227 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiologic testing of bretylium tosylate in sustained ventricular tachycardia. Bauernfeind RA; Hoff JV; Swiryn S; Palileo E; Strasberg B; Scagliotti D; Rosen KM Am Heart J; 1983 Jun; 105(6):973-80. PubMed ID: 6858846 [TBL] [Abstract][Full Text] [Related]
14. Bretylium tosylate in patients with acute myocardial infarction. Torresani J Am J Cardiol; 1984 Jul; 54(2):20A-25A. PubMed ID: 6464996 [TBL] [Abstract][Full Text] [Related]
15. Bretylium tosylate: profile of the only available class III antiarrhythmic agent. Anderson JL Clin Ther; 1985; 7(2):205-24. PubMed ID: 3886143 [TBL] [Abstract][Full Text] [Related]
16. Bretylium tosylate in prevention of cardiac dysrhythmias after myocardial infarction. Taylor SH; Saxton C; Davies PS; Stoker JB Br Heart J; 1970 May; 32(3):326-9. PubMed ID: 4911756 [TBL] [Abstract][Full Text] [Related]
17. Deleterious effects of bretylium on hemodynamic recovery from ventricular fibrillation. Euler DE; Zeman TW; Wallock ME; Scanlon PJ Am Heart J; 1986 Jul; 112(1):25-31. PubMed ID: 3728284 [TBL] [Abstract][Full Text] [Related]
18. The influence of bretylium tosylate on the intraocular pressure of the rabbit. Krieglstein GK Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1975 Nov; 197(2):153-8. PubMed ID: 1082263 [TBL] [Abstract][Full Text] [Related]